News for Healthier Living
New ACS Prostate Cancer Statistics Report: Late-Stage Incidence Rates Continue to Increase Rapidly as Mortality Declines Slow
 Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate cancer incidence rates have reversed from a decline of 6.4% per year during 2007 through 2014 to an increase of 3.0% annually during 2014 through 2021, with the steepest increase (4.6%-4.8% per year) for advanced-stage diagnoses. Simultaneously, mortality declines slowed from 3%-4% per year during the 1990s and 2000s to 0.6% per year over the past decade. These major findings are to be published today in the journal CA: A Cancer Journal for Clinicians.
September 2, 2025
September 2 2025September 1 2025August 31 2025August 30 2025August 29 2025August 28 2025August 27 2025August 26 2025August 25 2025August 24 2025August 23 2025August 22 2025August 21 2025August 20 2025 - The Tiniest Touch, The Greatest Hope
- International Collaboration on Nursing and Midwifery in the Caribbean Deemed a Success, According to New Study
- How the Indirect Effects of Nurture NJ Bolster Maternal Health Initiatives
- Unique Active Memory Computer Purpose-built for AI Science Applications
- A New, Non-Addictive Painkiller is on the Horizon
- AABB Updates Transfusion Standards After Another Massive Carson Study
- Pedestrian Safety Tips
- Parkinson's Disease Risk Increases with Metabolic Syndrome
- FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia
- AAP Issues New Vaccine Guidelines That Differ From U.S. Government Advice
- FDA Approves Wegovy to Treat Serious Liver Disease
- Walmart Recalls Frozen Shrimp Over FDA Warning About Radiation Risk
- New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
- New Cleveland Clinic Research Identifies Link Between Gut Microbes and an Elevated Risk for Abdominal Aortic Aneurysms
- Weather Disasters Increase Risk for U.S. Drug Supply Chain Disruption, New ACS Research Shows
- Cancer-Associated Nerve Injury Leads to Chronic Inflammation and Immunotherapy Resistance
- 'Philadelphia Consensus' Sets New Standard for Treating Devastating Xylazine-Related Injuries
- Researchers Map Epigenomic Landscapes of Fat Tissue Cells, Revealing How They Shape Obesity Risk
- Bullied Teens Less Likely to Be Depressed if They Feel Connected at School, Study Shows
- Seniors Neglecting Steps To Protect Heart Health, Study Says
- Pesticide Linked To Impaired Brain Development Among Kids
- Sensitive People More Vulnerable To Mood Disorders
- Do No Harm: Rethink Treating Diabetes, Hypertension in Frail Older Adults
- Tight Blood Pressure Control Both Healthy And Cost-Effective, Projections Say
- Thin Endometrium Shouldn't Lower Odds Of Successful IVF Pregnancy, Study Says
- COVID Can Prematurely Age Blood Vessels
- Plant-Based Diets Can Reduce the Risk of Multimorbidity
- Building a Better Database to Detect Designer Drugs
- New Graphene Technology Matures Brain Organoids Faster, May Unlock Neurodegenerative Insights
August 19 2025
|
|
|
|
|